Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
---|---|
Enthalten in: |
International journal of antimicrobial agents - 56(2020), 2 vom: 15. Aug., Seite 106066 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Iannaccone, Marco [VerfasserIn] |
---|
Links: |
---|
Themen: |
1C75676F8V |
---|
Anmerkungen: |
Date Completed 23.04.2021 Date Revised 23.04.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijantimicag.2020.106066 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311773206 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311773206 | ||
003 | DE-627 | ||
005 | 20231225142956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijantimicag.2020.106066 |2 doi | |
028 | 5 | 2 | |a pubmed24n1039.xml |
035 | |a (DE-627)NLM311773206 | ||
035 | |a (NLM)32599226 | ||
035 | |a (PII)S0924-8579(20)30236-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Iannaccone, Marco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.04.2021 | ||
500 | |a Date Revised 23.04.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Bacterial Proteins |2 NLM | |
650 | 7 | |a Boronic Acids |2 NLM | |
650 | 7 | |a Drug Combinations |2 NLM | |
650 | 7 | |a vaborbactam |2 NLM | |
650 | 7 | |a 1C75676F8V |2 NLM | |
650 | 7 | |a beta-Lactamases |2 NLM | |
650 | 7 | |a EC 3.5.2.6 |2 NLM | |
650 | 7 | |a carbapenemase |2 NLM | |
650 | 7 | |a EC 3.5.2.6 |2 NLM | |
650 | 7 | |a Meropenem |2 NLM | |
650 | 7 | |a FV9J3JU8B1 |2 NLM | |
700 | 1 | |a Boattini, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Bianco, Gabriele |e verfasserin |4 aut | |
700 | 1 | |a Cavallo, Rossana |e verfasserin |4 aut | |
700 | 1 | |a Costa, Cristina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of antimicrobial agents |d 1991 |g 56(2020), 2 vom: 15. Aug., Seite 106066 |w (DE-627)NLM090678974 |x 1872-7913 |7 nnns |
773 | 1 | 8 | |g volume:56 |g year:2020 |g number:2 |g day:15 |g month:08 |g pages:106066 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijantimicag.2020.106066 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 56 |j 2020 |e 2 |b 15 |c 08 |h 106066 |